Model acetylcholinesterase-Fc fusion glycoprotein biotechnology system for the manufacture of an organophosphorus toxicant bioscavenging countermeasure.

Autor: Biel TG; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Faison T; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Matthews AM; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Ortega-Rodriguez U; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Falkowski VM; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Meek E; Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences College of Veterinary Medicine, Mississippi State University Mississippi State Mississippi USA., Bush X; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA.; Department of Biomedical and Pharmaceutical Sciences College of Pharmacy, University of Rhode Island Kingston Rhode Island USA., Flores M; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Johnson S; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Wu WW; Facility for Biotechnology Resources Center for Biologics Evaluation and Research, United States Food and Drug Administration Silver Spring Maryland USA., Lehtimaki M; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Shen RF; Facility for Biotechnology Resources Center for Biologics Evaluation and Research, United States Food and Drug Administration Silver Spring Maryland USA., Agarabi C; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Rao VA; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA., Chambers JE; Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences College of Veterinary Medicine, Mississippi State University Mississippi State Mississippi USA., Ju T; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring Maryland USA.

Publikováno v: Bioengineering & translational medicine [Bioeng Transl Med] 2024 Apr 25; Vol. 9 (5), pp. e10666. Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024).

Real time on-line amino acid analysis to explore amino acid trends and link to glycosylation outcomes of a model monoclonal antibody.

Autor: Azer N; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Trunfio N; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Fratz-Berilla EJ; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Hong JS; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA.; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies (OTAT), Division of Cellular and Gene Therapies (DCGT), Silver Spring, Maryland, USA., Cullinan J; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Faison T; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Agarabi CD; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA., Powers DN; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, Maryland, USA.

Publikováno v: Biotechnology progress [Biotechnol Prog] 2023 Jul-Aug; Vol. 39 (4), pp. e3347. Date of Electronic Publication: 2023 Apr 27.

Basin-scale reconstruction of euxinia and Late Devonian mass extinctions.

Autor: Sahoo SK; Equinor US, Houston, TX, USA. swas@equinor.com., Gilleaudeau GJ; George Mason University, Fairfax, VA, USA., Wilson K; Boston College, Chestnut Hill, MA, USA., Hart B; Equinor US, Houston, TX, USA.; University of Western Ontario, London, Ontario, Canada., Barnes BD; Pennsylvania State University, University Park, PA, USA., Faison T; University of Maryland, College Park, MD, USA., Bowman AR; Gaia Paleontological Services LLC, Missouri City, TX, USA., Larson TE; Bureau of Economic Geology, University of Texas at Austin, Austin, TX, USA., Kaufman AJ; University of Maryland, College Park, MD, USA.

Publikováno v: Nature [Nature] 2023 Mar; Vol. 615 (7953), pp. 640-645. Date of Electronic Publication: 2023 Mar 08.

Linking Antiracist Action From the Classroom to Practice.

Autor: Johnson KR; Khalilah R. Johnson, PhD, OTR/L, is Assistant Professor, Division of Occupational Science and Occupational Therapy, University of North Carolina at Chapel Hill; khalilah_johnson@med.unc.edu., Kirby A; Anne Kirby, PhD, OTR/L, is Associate Professor, Department of Occupational and Recreational Therapies, University of Utah, Salt Lake City., Washington S; Selena Washington, PhD, OTR/L, is Assistant Professor, Department of Occupational Science and Occupational Therapy, Saint Louis University, St. Louis, MO., Lavalley R; Ryan Lavalley, PhD, OTR/L, is Assistant Professor, Division of Occupational Science and Occupational Therapy, University of North Carolina at Chapel Hill., Faison T; Tomeico Faison, OTD, OTR/L, is CEO and Occupational Therapist, Therapeutic Solutions of North Carolina, Cary, and Minority Recruitment and Retention Faculty, OTD Program, Duke University, Durham, NC.

Publikováno v: The American journal of occupational therapy : official publication of the American Occupational Therapy Association [Am J Occup Ther] 2022 Sep 01; Vol. 76 (5).

Interview with Heidi Jannenga.

Autor: Faison T; Faculty Member, Duke University, Durham, NC, USA; Teaching Assistant, Boston University, Boston, MA, USA Email: tomeico@tsofnc.com.

Publikováno v: Work (Reading, Mass.) [Work] 2022; Vol. 72 (2), pp. 387-389.